Showing results (1411-1420 of 8,878) with videos related to

Sort By:
Pageof 888
BJU International|December 13, 2006
Liver metastases in prostate carcinoma: clinical characteristics and outcomeDamien Pouessel, Blandine Gallet, Frédéric Bibeau, et al.
BJU International|December 13, 2006
Comparison of traditional basal and apical periprostatic block: impact on injection pain and biopsy painCarvell T Nguyen, J Stephen Jones
BJU International|December 13, 2006
An abnormal digital rectal examination is an independent predictor of Gleason > or =7 prostate cancer in men undergoing initial prostate biopsy: a prospective study of 790 menLester S Borden, Jonathan L Wright, Jason Kim, et al.
BJU International|December 13, 2006
S-allylcysteine, a water-soluble garlic derivative, suppresses the growth of a human androgen-independent prostate cancer xenograft, CWR22R, under in vivo conditionsQingjun Chu, Davy T W Lee, Sai Wah Tsao, et al.
BJU International|December 13, 2006
Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladderGuido Dalbagni, Dipen J Parekh, Leah Ben-Porat, et al.
BJU International|December 13, 2006
Impact of positive surgical margins in patients undergoing partial nephrectomy for renal cortical tumoursEric O Kwon, Brett S Carver, Mark E Snyder, et al.
BJU International|December 13, 2006
Significance of micrometastases in pelvic lymph nodes detected by real-time reverse transcriptase polymerase chain reaction in patients with clinically localized prostate cancer undergoing radical prostatectomy after neoadjuvant hormonal therapyHideaki Miyake, Toshifumi Kurahashi, Isao Hara, et al.
BJU International|December 13, 2006
The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397)Richard J Stephens, David P Dearnaley, Richard Cowan, et al.
BJU International|June 8, 2007
The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomyErica H Lambert, Phillip M Pierorazio, Carl A Olsson, et al.
BJU International|June 8, 2007
A randomized prospective trial evaluating testosterone, haemoglobin kinetics and quality of life, during and after 12 months of androgen deprivation after prostatectomy: results from the Postoperative Adjuvant Androgen Deprivation trialPeter C Black, Karen Basen-Engquist, Xuemei Wang, et al.
Pageof 888